Chapter/Section Purchase

1 Study Coverage
1.1 Organ Transplant Rejection Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Organ Transplant Rejection Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Steroids
1.2.3 Antibodies
1.2.4 mTOR Inhibitors
1.2.5 Antiproliferative Agents
1.2.6 Calcineurin Inhibitors
1.3 Market by Application
1.3.1 Global Organ Transplant Rejection Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Kidney Transplant
1.3.3 Bone Marrow Transplant
1.3.4 Liver Transplant
1.3.5 Heart Transplant
1.3.6 Lung Transplant
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Organ Transplant Rejection Medicine Sales Estimates and Forecasts 2017-2028
2.2 Global Organ Transplant Rejection Medicine Revenue Estimates and Forecasts 2017-2028
2.3 Global Organ Transplant Rejection Medicine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Organ Transplant Rejection Medicine Sales by Region
2.4.1 Global Organ Transplant Rejection Medicine Sales by Region (2017-2022)
2.4.2 Global Sales Organ Transplant Rejection Medicine by Region (2023-2028)
2.5 Global Organ Transplant Rejection Medicine Revenue by Region
2.5.1 Global Organ Transplant Rejection Medicine Revenue by Region (2017-2022)
2.5.2 Global Organ Transplant Rejection Medicine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Organ Transplant Rejection Medicine Sales by Manufacturers
3.1.1 Global Top Organ Transplant Rejection Medicine Manufacturers by Sales (2017-2022)
3.1.2 Global Organ Transplant Rejection Medicine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Organ Transplant Rejection Medicine in 2021
3.2 Global Organ Transplant Rejection Medicine Revenue by Manufacturers
3.2.1 Global Organ Transplant Rejection Medicine Revenue by Manufacturers (2017-2022)
3.2.2 Global Organ Transplant Rejection Medicine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Organ Transplant Rejection Medicine Revenue in 2021
3.3 Global Organ Transplant Rejection Medicine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Organ Transplant Rejection Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Organ Transplant Rejection Medicine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Organ Transplant Rejection Medicine Sales by Type
4.1.1 Global Organ Transplant Rejection Medicine Historical Sales by Type (2017-2022)
4.1.2 Global Organ Transplant Rejection Medicine Forecasted Sales by Type (2023-2028)
4.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Type (2017-2028)
4.2 Global Organ Transplant Rejection Medicine Revenue by Type
4.2.1 Global Organ Transplant Rejection Medicine Historical Revenue by Type (2017-2022)
4.2.2 Global Organ Transplant Rejection Medicine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Type (2017-2028)
4.3 Global Organ Transplant Rejection Medicine Price by Type
4.3.1 Global Organ Transplant Rejection Medicine Price by Type (2017-2022)
4.3.2 Global Organ Transplant Rejection Medicine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Organ Transplant Rejection Medicine Sales by Application
5.1.1 Global Organ Transplant Rejection Medicine Historical Sales by Application (2017-2022)
5.1.2 Global Organ Transplant Rejection Medicine Forecasted Sales by Application (2023-2028)
5.1.3 Global Organ Transplant Rejection Medicine Sales Market Share by Application (2017-2028)
5.2 Global Organ Transplant Rejection Medicine Revenue by Application
5.2.1 Global Organ Transplant Rejection Medicine Historical Revenue by Application (2017-2022)
5.2.2 Global Organ Transplant Rejection Medicine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Organ Transplant Rejection Medicine Revenue Market Share by Application (2017-2028)
5.3 Global Organ Transplant Rejection Medicine Price by Application
5.3.1 Global Organ Transplant Rejection Medicine Price by Application (2017-2022)
5.3.2 Global Organ Transplant Rejection Medicine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Organ Transplant Rejection Medicine Market Size by Type
6.1.1 North America Organ Transplant Rejection Medicine Sales by Type (2017-2028)
6.1.2 North America Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
6.2 North America Organ Transplant Rejection Medicine Market Size by Application
6.2.1 North America Organ Transplant Rejection Medicine Sales by Application (2017-2028)
6.2.2 North America Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
6.3 North America Organ Transplant Rejection Medicine Market Size by Country
6.3.1 North America Organ Transplant Rejection Medicine Sales by Country (2017-2028)
6.3.2 North America Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Organ Transplant Rejection Medicine Market Size by Type
7.1.1 Europe Organ Transplant Rejection Medicine Sales by Type (2017-2028)
7.1.2 Europe Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
7.2 Europe Organ Transplant Rejection Medicine Market Size by Application
7.2.1 Europe Organ Transplant Rejection Medicine Sales by Application (2017-2028)
7.2.2 Europe Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
7.3 Europe Organ Transplant Rejection Medicine Market Size by Country
7.3.1 Europe Organ Transplant Rejection Medicine Sales by Country (2017-2028)
7.3.2 Europe Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Organ Transplant Rejection Medicine Market Size by Type
8.1.1 Asia Pacific Organ Transplant Rejection Medicine Sales by Type (2017-2028)
8.1.2 Asia Pacific Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
8.2 Asia Pacific Organ Transplant Rejection Medicine Market Size by Application
8.2.1 Asia Pacific Organ Transplant Rejection Medicine Sales by Application (2017-2028)
8.2.2 Asia Pacific Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
8.3 Asia Pacific Organ Transplant Rejection Medicine Market Size by Region
8.3.1 Asia Pacific Organ Transplant Rejection Medicine Sales by Region (2017-2028)
8.3.2 Asia Pacific Organ Transplant Rejection Medicine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Organ Transplant Rejection Medicine Market Size by Type
9.1.1 Latin America Organ Transplant Rejection Medicine Sales by Type (2017-2028)
9.1.2 Latin America Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
9.2 Latin America Organ Transplant Rejection Medicine Market Size by Application
9.2.1 Latin America Organ Transplant Rejection Medicine Sales by Application (2017-2028)
9.2.2 Latin America Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
9.3 Latin America Organ Transplant Rejection Medicine Market Size by Country
9.3.1 Latin America Organ Transplant Rejection Medicine Sales by Country (2017-2028)
9.3.2 Latin America Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Type
10.1.1 Middle East and Africa Organ Transplant Rejection Medicine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Type (2017-2028)
10.2 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Application
10.2.1 Middle East and Africa Organ Transplant Rejection Medicine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Application (2017-2028)
10.3 Middle East and Africa Organ Transplant Rejection Medicine Market Size by Country
10.3.1 Middle East and Africa Organ Transplant Rejection Medicine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Organ Transplant Rejection Medicine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Corporation Information
11.1.2 GlaxoSmithKline plc Overview
11.1.3 GlaxoSmithKline plc Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline plc Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline plc Recent Developments
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Overview
11.2.3 Novartis AG Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novartis AG Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novartis AG Recent Developments
11.3 F. Hoffmann-La Roche Ltd.
11.3.1 F. Hoffmann-La Roche Ltd. Corporation Information
11.3.2 F. Hoffmann-La Roche Ltd. Overview
11.3.3 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 F. Hoffmann-La Roche Ltd. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.4 Astellas Pharma, Inc.
11.4.1 Astellas Pharma, Inc. Corporation Information
11.4.2 Astellas Pharma, Inc. Overview
11.4.3 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Astellas Pharma, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Astellas Pharma, Inc. Recent Developments
11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Corporation Information
11.5.2 Pfizer, Inc. Overview
11.5.3 Pfizer, Inc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer, Inc. Recent Developments
11.6 AbbVie, Inc.
11.6.1 AbbVie, Inc. Corporation Information
11.6.2 AbbVie, Inc. Overview
11.6.3 AbbVie, Inc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 AbbVie, Inc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 AbbVie, Inc. Recent Developments
11.7 Allergan plc.
11.7.1 Allergan plc. Corporation Information
11.7.2 Allergan plc. Overview
11.7.3 Allergan plc. Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Allergan plc. Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Allergan plc. Recent Developments
11.8 Bristol-Myers Squibb Company
11.8.1 Bristol-Myers Squibb Company Corporation Information
11.8.2 Bristol-Myers Squibb Company Overview
11.8.3 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Bristol-Myers Squibb Company Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Company Recent Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Overview
11.9.3 Sanofi Organ Transplant Rejection Medicine Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Sanofi Organ Transplant Rejection Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Organ Transplant Rejection Medicine Industry Chain Analysis
12.2 Organ Transplant Rejection Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Organ Transplant Rejection Medicine Production Mode & Process
12.4 Organ Transplant Rejection Medicine Sales and Marketing
12.4.1 Organ Transplant Rejection Medicine Sales Channels
12.4.2 Organ Transplant Rejection Medicine Distributors
12.5 Organ Transplant Rejection Medicine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Organ Transplant Rejection Medicine Industry Trends
13.2 Organ Transplant Rejection Medicine Market Drivers
13.3 Organ Transplant Rejection Medicine Market Challenges
13.4 Organ Transplant Rejection Medicine Market Restraints
14 Key Findings in The Global Organ Transplant Rejection Medicine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer